Tepnel and SoftGenetics to offer rapid analytics for congenital
27 August 2008
Manchester-based Tepnel Life Sciences plc (AIM: TED) and
Pennsylvania-based SoftGenetics have announced an agreement to market
and distribute SoftGenetics GeneMarker genotyping software for use with
Tepnel’s Elucigene QST*R products for prenatal detection of common
Tepnel’s Elucigene QST*R kits are a range of rapid DNA diagnostic
tests that use STR markers to detect the three most common viable
autosomal trisomies: trisomy 21 (Down syndrome), trisomy 18 (Edwards
syndrome) and trisomy 13 (Patau syndrome).
The combination of SoftGenetics GeneMarker software with QST*R will
considerably streamline the data analysis process and results reporting
time for users of the Elucigene diagnostic test kits.
Elucigene QST*R tests cover a range of DNA-based multiplexed
diagnostic assays that use short tandem repeat (STR) markers to detect
the three most common viable autosomal trisomies: Down syndrome, Edwards
syndrome and Patau syndrome.
Additional markers on the sex chromosomes X and Y can detect the most
common sex chromosome aneuploidies, Klinefelter syndrome and Turner
Developed in collaboration with Guy’s and St Thomas’ Hospital,
London, Elucigene QST*R is a rapid testing technique that provides
definitive results within 4 hours, including DNA extraction.